BERYL ELITES KNOWLEDGE CENTER
PANEL – Investing in Innovators, Cannabinoids versus Opioids for Chronic Pain Care
Beryl Elites – NYC October 2017.
Panelists: ❖ Andrea Bartzen, Moderator ❖ Jeff Margolis, CFO, RespireX Pharmaceuticals ❖ Jeffrey Friedland, CEO, FC Global Stratgies ❖ Jason Criscione Ph.D, Chief Scientific Officer of Mobius Biomedical
Don’t forget to subscribe to Beryl Elites YouTube channel for updates *
Visit the Beryl Elites Knowledge Center at berylelites.com/bkc for more primary sources and Beryl-ROI Curated Industry News at https://berylelites.com/beryl-roi-news
Copyright 2020 The Beryl Consulting Group. All Rights Reserved.